K915730 is an FDA 510(k) clearance for the MORTARA INSTRUMENT ODEL ELI 50I.
Submitted by Mortara Instrument, Inc. (Milwaukee, US). The FDA issued a Cleared decision on November 10, 1992 after a review of 326 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.